A82-53408-25986
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 603 / IL
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
Q3X-61543-10143
Child or adolescent in my care · Male · 2022-09-27
GWS-28580-02419
Child or adolescent in my care · Male · 2022-10-05
Timeline
-
2021-01-02
Dose 1 — Moderna
-
2021-01-03
Registered in v-safe
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-01-06
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-01-09
Survey response — day 7, dose 1MedDRA: Injection site induration — Feeling: Good · Site: Redness, Swelling, Itching · Fatigue or tirednessFree text: Injection site firm to the touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — day 14, dose 1MedDRA: Injection site pruritus, Injection site rash, Injection site swelling — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Injection site rash return and was swollen and itchy and larger than initial one.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-23
-
2021-01-30
Dose 2 — Moderna
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-15
- 2021-05-02
- 2021-08-02
-
2021-12-23
Dose 3 — Moderna
- 2021-12-23
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-12-25
- 2021-12-26
- 2021-12-27
- 2021-12-29
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-03-24
- 2022-06-23
- 2022-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna | |
| 2 | 2021-01-30 | Moderna | |
| 3 | 2021-12-23 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Injection site firm to the touch
Release 2 — day 14, dose 1
Symptoms: Injection site rash return and was swollen and itchy and larger than initial one.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release